American Healthcare REIT stock jumped 3.7% to US$56.74 after the Q2 release, a quick reward for holders who had already seen a roughly 10% gain over the past three months. The headline is not the share price. It is cash generation. Normalized funds from operations, or FFO, came in at US$0.54 per diluted share and management lifted full year FFO guidance to US$2.15 to US$2.19.

That move in guidance, backed by 13.2% same store net operating income growth, is what matters for anyone thinking beyond this week and toward the multi year healthcare real estate build out.

Like the cash generation story at American Healthcare REIT but want more ideas with strong balance sheets and steady cash flow? Take a look at the list of solid balance sheet and fundamentals stocks (49 results).

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs. Q2 2025): US$674.25 million vs. US$541.27 million (up 24.6%)
• Net Income (Q2 2026 vs. Q2 2025): US$30.61 million vs. US$9.91 million (up 208.8%)
• Basic EPS (Q2 2026 vs. Q2 2025): US$0.16 per share vs. US$0.06 per share (up 157.3%)
• Funds From Operations (FFO, Q2 2026 vs. Q2 2025): US$90.35 million vs. US$66.80 million (up 35.3%)

If you prefer clear visuals instead of long earnings tables and raw figures, you can see American Healthcare REIT's full financial picture, including how its balance sheet compares, in an easy to read visual format in our company report for American Healthcare REIT.

American Healthcare REIT Bull Story Meets Hard Data

Fans of American Healthcare REIT argue that demographic demand plus a better portfolio and stronger operators will steadily turn into higher quality cash flow. Q2 goes a fair way toward backing that up. Same store NOI rose 13.2% with Trilogy at 16.1% and SHOP at 20.5%, which lines up with the idea that higher acuity senior housing and campuses can carry the growth. Margins are moving the right way, with Trilogy and SHOP both expanding, and occupancy in Trilogy at 90.7% supports the claim that real estate is being matched to real demand. Normalized FFO of US$0.54 per share and the lift in full year FFO guidance to US$2.15 to US$2.19 show cash generation tracking ahead of earlier expectations. A cleaner balance sheet with net debt to EBITDA at 2.5x also fits the bullish narrative that recent equity raises have set up a more resilient platform.

Bear Case Checks: Growth, Capital Raises, Index Shift

The bear story focuses on growth slowing as comps get harder, equity dilution, and risk that outpatient medical and reimbursement trends cap returns. Q2 partially challenges that view but does not close the book. Same store NOI guidance for 2026 is now 11% to 13%, and management explicitly kept the pipeline out of guidance, so current growth is still coming from the existing base rather than just deals. At the same time, Q2 included roughly US$1.5b of equity raised with another US$631m of forwards to settle, which means the share count is moving higher just as American Healthcare REIT leans into a large acquisition pipeline. Outpatient medical guidance of flat to 1% and triple net at 2% to 3% shows that not every segment is firing, which keeps alive concerns that some parts of the portfolio could act as a drag if sector conditions tighten.

Reveal where the apparent calm around American Healthcare REIT's current share price gives way to real disagreement about the next leg of growth. Access the multi year revenue, FFO and dividend path in the street's analyst estimates for American Healthcare REIT.

Stay Ahead With Simply Wall St

If the Q2 cash generation story at American Healthcare REIT has your attention, register for free with Simply Wall St and add it to a Watchlist so you can track the share price against fair value and watch how future FFO updates affect your ideal entry point. Once you are invested, use the Portfolio Command Center to cut through market noise and focus on the key developments that matter to your holdings. For a broader view, tap into crowd insights and different theses through the Community so you can see how other investors are thinking about risks and opportunities. By surfacing hidden catalysts and potential red flags early, Simply Wall St helps you stay a step ahead of the market and make more confident decisions.

Seeking Alternatives Beyond American Healthcare REIT

Fresh stock ideas can move quickly from quiet to crowded once momentum builds and prices start flying. Scan these under the radar picks before the crowd and get in early.

• Spot companies with strong cash generation and sturdy balance sheets by reviewing the curated 49 high quality undervalued stocks while the valuations still look reasonable and entry points have not been crowded out.
• Ride structural demand in critical materials by scanning the hand picked 28 best rare earth metal stocks before any supply shocks or contract wins get fully reflected in share prices.
• Target structural growth in computing power by reviewing the carefully filtered 55 AI infrastructure stocks while many of these stocks are still flying under wider market radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.